Mental and Behavioural Disorders Depression ,sexual dysfunction
Conditions
Interventions
DMPA (Depot-Provera®, Pfizer)
LNG implant 150mg (Jadelle®, Bayer Schering Pharma
IUD (Paragard-T 380A®, Duramed).
Sponsors
Effective Care Research Unit
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: ¿ 16 to 35 years of age ¿ HIV sero-negative at baseline ¿ Seeking effective contraception ¿ Able and willing to provide written informed consent ¿ Agrees to be randomised to either the copper IUD, DMPA, or LNG implant ¿ Agrees to use assigned method for 18 months ¿ Agrees to follow all study requirements ¿ Intends to stay in the study area for the next 18 months and willing and able to provide adequate locator information ¿ If has had a recent third trimester birth, is at least 6 weeks¿ postpartum ¿ Is sexually active (has had vaginal sex within the last 3 months) or has been pregnant within the last 3 months ¿ Agrees not to participate in studies of drugs or vaccines or any other clinical research study while participating in this study
Exclusion criteria
Exclusion criteria: Women are not eligible to participate if they have medical contraindications to the IUD, DMPA, or LNG implant (WHO Medical Eligibility Criteria category 3 or 4),
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Depression | — |
Countries
South Africa
Contacts
Public ContactMandisa Singata-Madliki
Co-Director, ECRU
Outcome results
None listed